Media-OutReach Newswire The United Laboratories and Novo Nordisk announce exclusive license agreement for UBT251, a GLP-1/GIP/glucagon triple receptor agonist
Media-OutReach Newswire CGTN: From GDP growth to tech, foreign investment boost, China brings confidence to the world in 2025
Sports Việt Nam bikes ruined in fire ahead of Asian cycling championship, organisers promise support
Or Tor Kor Elevates Thai Agricultural Products on the Global Stage with "IFEX Connect 2025" in Manila 1.